Dextera Surgical Inc. (NASDAQ:DXTR) shares gapped up prior to trading on Wednesday . The stock had previously closed at $0.32, but opened at $0.33. Dextera Surgical shares last traded at $0.34, with a volume of 3,402,308 shares trading hands.

Several research analysts recently commented on the company. Zacks Investment Research downgraded Dextera Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Ladenburg Thalmann Financial Services began coverage on Dextera Surgical in a research note on Wednesday, August 16th. They issued a “buy” rating and a $0.80 price objective for the company. Finally, Wedbush cut their target price on Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating for the company in a research note on Wednesday, July 12th.

The stock has a 50 day moving average price of $0.29 and a 200 day moving average price of $0.56. The company’s market capitalization is $5.96 million.

Dextera Surgical (NASDAQ:DXTR) last posted its earnings results on Tuesday, August 8th. The medical instruments supplier reported ($0.40) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.11) by $0.29. The business had revenue of $1.05 million during the quarter, compared to the consensus estimate of $1.03 million. On average, analysts anticipate that Dextera Surgical Inc. will post ($0.24) earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DXTR. Broadfin Capital LLC raised its holdings in shares of Dextera Surgical by 64.7% in the second quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock worth $296,000 after acquiring an additional 388,080 shares during the last quarter. Virtu KCG Holdings LLC raised its holdings in shares of Dextera Surgical by 1,380.6% in the second quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock worth $111,000 after acquiring an additional 344,933 shares during the last quarter. Finally, Perkins Capital Management Inc. acquired a new position in shares of Dextera Surgical in the second quarter worth $100,000. 7.78% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/09/08/dextera-surgical-inc-dxtr-shares-gap-up-to-0-33-2.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.